Serotype Distribution and Antimicrobial Susceptibilities of Invasive Streptococcus Pneumoniae Isolates from Adults in Korea from 1997 to 2012

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2016 May 3

PMID 27134492

Citations 4

Authors

Chung Jong Kim

Jin-Su Song

Su-Jin Choi

Kyoung Ho Song

Pyeong Gyun Choe

Wan Beom Park

Ji Hwan Bang

Eu Suk Kim

Sang Won Park

Hong Bin Kim

Nam-Joong Kim

Eui-Chong Kim

Myoung-Don Oh

Affiliations

Soon will be listed here.

Abstract

In Republic of Korea, a 7-valent pneumococcal conjugated vaccine (PCV7) was licensed for use in infants in 2003, and 13-valent PCV (PCV13) replaced it since 2010. We investigated trends in serotype distribution and antibiotic susceptibility of pneumococcal isolates from adult patients with invasive pneumococcal diseases (IPD). Invasive pneumococcal isolates from adult patients of ≥ 16 years of age were collected from 1997 to 2012. Serotypes of the isolates were determined by the Quellung reaction. Distribution of serotypes was analyzed according to the vaccine types. Antibiotic susceptibility was tested by using E-test strips. A total of 272 invasive pneumococcal isolates were included. The most common serotypes were serotype 19F (8.5%, 23/272), and serotype 3 (8.1%, 22/272), and 24.6% (67/272) of the isolates were of non-vaccine serotypes. Of the 272 isolates, 2.6% (7/272) were penicillin MICs of ≥ 4 µg/mL. The proportion of the PCV13 serotypes decreased from 63.3% (50/79) in 1997-2003 to 48.6% (17/35) in 2011-2012, whereas that of non-vaccine serotypes was 26.6% (21/79) and 25.7% (9/35), respectively, for the same periods. The proportion of the PCV13 serotypes showed a decreasing trend among adult patients with IPD over the study period.

Citing Articles

Pre- & post-vaccine trends in pneumococcal serotypes & antimicrobial resistance patterns.

Peela S, Sistla S, Nagaraj G, Govindan V, Kadahalli R Indian J Med Res. 2024; 160(3&4):354-361.

PMID: 39632638 PMC: 11619032. DOI: 10.25259/ijmr_1811_23.

Pneumococcal disease burden in high-risk older adults: Exploring impact of comorbidities, long-term care facilities, antibiotic resistance, and immunization policies through a narrative literature review.

Cheong D, Song J Hum Vaccin Immunother. 2024; 20(1):2429235.

PMID: 39631047 PMC: 11622649. DOI: 10.1080/21645515.2024.2429235.

Serotype Distribution and Antimicrobial Resistance of Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine.

Kim G, Kim E, Kim S, Lee H, Lee J, Shin J Ann Lab Med. 2022; 43(1):45-54.

PMID: 36045056 PMC: 9467834. DOI: 10.3343/alm.2023.43.1.45.

Nasopharyngeal Carriage of Antimicrobial-Resistant Pneumococci in an Intensively Sampled South African Birth Cohort.

Manenzhe R, Moodley C, Abdulgader S, Robberts F, Zar H, Nicol M Front Microbiol. 2019; 10:610.

PMID: 30972052 PMC: 6446970. DOI: 10.3389/fmicb.2019.00610.

References

Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen J . Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000; 19(3):187-95. DOI: 10.1097/00006454-200003000-00003. View

Brueggemann A, Griffiths D, Meats E, Peto T, Crook D, Spratt B . Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis. 2003; 187(9):1424-32. DOI: 10.1086/374624. View

HENRICHSEN J . Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol. 1995; 33(10):2759-62. PMC: 228570. DOI: 10.1128/jcm.33.10.2759-2762.1995. View

Dagan R, Melamed R, Muallem M, Piglansky L, Greenberg D, Abramson O . Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis. 1996; 174(6):1271-8. DOI: 10.1093/infdis/174.6.1271. View

Ihekweazu C, Dance D, Pebody R, George R, Smith M, Waight P . Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005. Epidemiol Infect. 2007; 136(8):1096-102. PMC: 2870895. DOI: 10.1017/S0950268807009715. View

Fenoll A, Granizo J, Aguilar L, Gimenez M, Aragoneses-Fenoll L, Hanquet G . Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009; 47(4):1012-20. PMC: 2668361. DOI: 10.1128/JCM.01454-08. View

Weinberger D, Trzcinski K, Lu Y, Bogaert D, Brandes A, Galagan J . Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 2009; 5(6):e1000476. PMC: 2689349. DOI: 10.1371/journal.ppat.1000476. View

Guevara M, Barricarte A, Gil-Setas A, Garcia-Irure J, Beristain X, Torroba L . Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain. Clin Microbiol Infect. 2009; 15(11):1013-9. DOI: 10.1111/j.1469-0691.2009.02904.x. View

Chiba N, Morozumi M, Sunaoshi K, Takahashi S, Takano M, Komori T . Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect. 2009; 138(1):61-8. DOI: 10.1017/S0950268809990239. View

10.

Pilishvili T, Lexau C, Farley M, Hadler J, Harrison L, Bennett N . Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2009; 201(1):32-41. DOI: 10.1086/648593. View

11.

Harboe Z, Benfield T, Valentiner-Branth P, Hjuler T, Lambertsen L, Kaltoft M . Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis. 2010; 50(3):329-37. DOI: 10.1086/649872. View

12.

Lee S, Lee K, Kang Y, Bae S . Prevalence of serotype and multidrug-resistance of Streptococcus pneumoniae respiratory tract isolates in 265 adults and 36 children in Korea, 2002-2005. Microb Drug Resist. 2010; 16(2):135-42. DOI: 10.1089/mdr.2009.0114. View

13.

Vickers I, Fitzgerald M, Murchan S, Cotter S, OFlanagan D, Cafferkey M . Serotype distribution of Streptococcus pneumoniae causing invasive disease in the Republic of Ireland. Epidemiol Infect. 2010; 139(5):783-90. DOI: 10.1017/S0950268810001743. View

14.

Ho P, Chiu S, Ang I, Lau Y . Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009. Vaccine. 2011; 29(17):3270-5. DOI: 10.1016/j.vaccine.2011.02.025. View

15.

Le C, Palanisamy N, Mohd Yusof M, Sekaran S . Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in Malaysia. PLoS One. 2011; 6(5):e19547. PMC: 3095606. DOI: 10.1371/journal.pone.0019547. View

16.

Rosen J, Thomas A, Lexau C, Reingold A, Hadler J, Harrison L . Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis. 2011; 53(2):137-43. DOI: 10.1093/cid/cir326. View

17.

Yasin R, Zin N, Hussin A, Haji Nawi S, Hanapiah S, Wahab Z . Current trend of pneumococcal serotypes distribution and antibiotic susceptibility pattern in Malaysian hospitals. Vaccine. 2011; 29(34):5688-93. DOI: 10.1016/j.vaccine.2011.06.004. View

18.

Vila-Corcoles A, Ochoa-Gondar O, Gomez-Bertomeu F, Raga-Luria X . Invasive pneumococcal disease in Catalonian elderly people, 2002-2009: serotype coverage for different anti-pneumococcal vaccine formulations at the beginning of the new conjugate vaccines era. Vaccine. 2011; 29(43):7430-4. DOI: 10.1016/j.vaccine.2011.07.066. View

19.

Weinberger D, Malley R, Lipsitch M . Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011; 378(9807):1962-73. PMC: 3256741. DOI: 10.1016/S0140-6736(10)62225-8. View

20.

Horacio A, Diamantino-Miranda J, Aguiar S, Ramirez M, Melo-Cristino J . Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections. Vaccine. 2011; 30(2):218-24. DOI: 10.1016/j.vaccine.2011.11.022. View